-
-
-
-
-
-
-
Biohaven Pharma (BHVN) Tops Q2 EPS by 31c
-
-
-
-
-
-
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd. - BHVN
-
-
-
-
-
-
-
Biohaven Pharma (BHVN) Misses Q4 EPS by 11c
-
-
-
-
-
-
-
2Q24 U.S. biotech earnings preview
-
-
-
-
-
-
-
Biohaven Reports Second Quarter 2023 Financial Results and Recent Business Developments
-
-
-
-
-
-
-
Biohaven Reports Second Quarter 2022 Financial Results and Reports Recent Business Developments
-
-
-
-
-
-
-
Biohaven Pharma (BHVN) Misses Q4 EPS by 22c, Revenue Beats
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

